Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer

Phase 2

Completed

Conditions: Esophageal Cancer
Gastric Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-06-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00005599

Locations: 🇺🇸
Albert Einstein Clinical Cancer Center, Bronx, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Trastuzumab in Treating Patients With Recurrent Osteosarcoma

Phase 2

Completed

Conditions: Sarcoma

First Posted Date: 2003-01-27

Last Posted Date: 2013-06-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00005033

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸
City of Hope Comprehensive Cancer Center, Duarte, California, United States
🇺🇸
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States

and more 1 locations

Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases

Phase 1

Completed

Conditions: Lung Cancer
Metastatic Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-06-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00004930

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States

Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia

Phase 1

Completed

Conditions: Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms

First Posted Date: 2003-01-27

Last Posted Date: 2013-06-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00006040

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma

Phase 1

Completed

Conditions: Intraocular Melanoma
Melanoma (Skin)

First Posted Date: 2003-01-27

Last Posted Date: 2013-06-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00005815

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer

Phase 2

Completed

Conditions: Ovarian Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-06-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00016224

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation

Not Applicable

Completed

Conditions: Anxiety Disorder
Chronic Myeloproliferative Disorders
Depression
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Pain

First Posted Date: 2003-01-27

Last Posted Date: 2013-06-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00014482

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors

Phase 2

Completed

Conditions: Gastrointestinal Carcinoid Tumor
Islet Cell Tumor
Lung Cancer
Neoplastic Syndrome

First Posted Date: 2003-01-27

Last Posted Date: 2013-06-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00027638

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma

Phase 2

Completed

Conditions: Sarcoma

First Posted Date: 2003-01-27

Last Posted Date: 2013-06-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00027716

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
University of Colorado Cancer Center at University of Colorado Health Sciences Center, Aurora, Colorado, United States
🇺🇸
University of Chicago Cancer Research Center, New York, New York, United States

and more 3 locations

Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Phase 2

Completed

Conditions: Leukemia

First Posted Date: 2003-01-27

Last Posted Date: 2013-06-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00045422

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy